The global contraceptive drugs market size is calculated at USD 19 billion in 2025 and is forecasted to reach around USD 31.60 billion by 2034, accelerating at a CAGR of 5.82% from 2025 to 2034. The North America contraceptive drugs market size surpassed USD 7.36 billion in 2024 and is expanding at a CAGR of 5.85% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Contraceptive Drugs Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Contraceptive Drugs Market, by Product
8.1.1 Oral
8.1.1.1. Market Revenue and Forecast
8.1.2. Lead Acid
8.1.2.1. Market Revenue and Forecast
8.1.3. Intrauterine Devices (IUD)
8.1.3.1. Market Revenue and Forecast
8.1.4. Condoms
8.1.4.1. Market Revenue and Forecast
8.1.5. Vaginal Ring
8.1.5.1. Market Revenue and Forecast
8.1.6. Subdermal Implants
8.1.6.1. Market Revenue and Forecast
8.1.7. Injectable
8.1.7.1. Market Revenue and Forecast
8.1.8. Others
8.1.8.1. Market Revenue and Forecast
9.1. Contraceptive Drugs Market, by Distribution Channel
9.1.1. Hospital Pharmacy
9.1.1.1. Market Revenue and Forecast
9.1.2. Retail Pharmacy
9.1.2.1. Market Revenue and Forecast
9.1.3. Clinics
9.1.3.1. Market Revenue and Forecast
9.1.4. Online Channel
9.1.4.1. Market Revenue and Forecast
9.1.5. Public Channel & NGOs
9.1.5.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. Contraceptive Drugs Market, by Age Group
10.1.1. 15–24 years
10.1.1.1. Market Revenue and Forecast
10.1.2. 25–34 years
10.1.2.1. Market Revenue and Forecast
10.1.3. 35–44 years
10.1.3.1. Market Revenue and Forecast
10.1.4. Above 44 years
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product
11.1.2. Market Revenue and Forecast, by Distribution Channel
11.1.3. Market Revenue and Forecast, by Age Group
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product
11.1.4.2. Market Revenue and Forecast, by Distribution Channel
11.1.4.3. Market Revenue and Forecast, by Age Group
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product
11.1.5.2. Market Revenue and Forecast, by Distribution Channel
11.1.5.3. Market Revenue and Forecast, by Age Group
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product
11.2.2. Market Revenue and Forecast, by Distribution Channel
11.2.3. Market Revenue and Forecast, by Age Group
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product
11.2.4.2. Market Revenue and Forecast, by Distribution Channel
11.2.4.3. Market Revenue and Forecast, by Age Group
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product
11.2.5.2. Market Revenue and Forecast, by Distribution Channel
11.2.5.3. Market Revenue and Forecast, by Age Group
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product
11.2.6.2. Market Revenue and Forecast, by Distribution Channel
11.2.6.3. Market Revenue and Forecast, by Age Group
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product
11.2.7.2. Market Revenue and Forecast, by Distribution Channel
11.2.7.3. Market Revenue and Forecast, by Age Group
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product
11.3.2. Market Revenue and Forecast, by Distribution Channel
11.3.3. Market Revenue and Forecast, by Age Group
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product
11.3.4.2. Market Revenue and Forecast, by Distribution Channel
11.3.4.3. Market Revenue and Forecast, by Age Group
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product
11.3.5.2. Market Revenue and Forecast, by Distribution Channel
11.3.5.3. Market Revenue and Forecast, by Age Group
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product
11.3.6.2. Market Revenue and Forecast, by Distribution Channel
11.3.6.3. Market Revenue and Forecast, by Age Group
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product
11.3.7.2. Market Revenue and Forecast, by Distribution Channel
11.3.7.3. Market Revenue and Forecast, by Age Group
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product
11.4.2. Market Revenue and Forecast, by Distribution Channel
11.4.3. Market Revenue and Forecast, by Age Group
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product
11.4.4.2. Market Revenue and Forecast, by Distribution Channel
11.4.4.3. Market Revenue and Forecast, by Age Group
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product
11.4.5.2. Market Revenue and Forecast, by Distribution Channel
11.4.5.3. Market Revenue and Forecast, by Age Group
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product
11.4.6.2. Market Revenue and Forecast, by Distribution Channel
11.4.6.3. Market Revenue and Forecast, by Age Group
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product
11.4.7.2. Market Revenue and Forecast, by Distribution Channel
11.4.7.3. Market Revenue and Forecast, by Age Group
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product
11.5.2. Market Revenue and Forecast, by Distribution Channel
11.5.3. Market Revenue and Forecast, by Age Group
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product
11.5.4.2. Market Revenue and Forecast, by Distribution Channel
11.5.4.3. Market Revenue and Forecast, by Age Group
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product
11.5.5.2. Market Revenue and Forecast, by Distribution Channel
11.5.5.3. Market Revenue and Forecast, by Age Group
12.1. Church & Dwight Co., Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Reckitt Benckiser Group Plc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Veru, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Organon Group of Companies
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Pfizer, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Teva Pharmaceutical Industries Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. The Cooper Companies, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Mayer Laboratories, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Agile Therapeutics
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. TherapeuticsmMD, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample